Dag Hjelle • 1959 • Oslo • 14 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
M MEDCIS AS	Managing Director/CEO	402,730	221,964	100 % directly
F FJORD MEDICAL AS	Managing Director/CEO	-	138,293	100 % indirectly
F FOLVENGAARD AQUA AS	Managing Director/CEO	-	534,500	48 % indirectly
P PURECUT TECHNOLOGIES AS	Managing Director/CEO	-	1,092,693	33.33 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
M MEDCIS AS	Chairman	402,730	221,964	100 % directly
F FJORD MEDICAL AS	Chairman	-	138,293	100 % indirectly
F FOLVENGAARD AS	Chairman	3,792,389	354,299	60 % directly
F FOLVENGAARD AQUA AS	Chairman	-	534,500	48 % indirectly
P PURECUT TECHNOLOGIES AS	Chairman	-	1,092,693	33.33 % indirectly
B BIOSYNTECH AS	Board Member	-	37,228	20 % indirectly
H HJELLEDALEN KRAFTLAG AS	Board Member	1,563,559	2,545,246	9.52 % directly
F FOLVENGAARD BIOGAS AS	Chairman	-	-	-
D DAG HJELLE	Holder	-	-	-
B BÆREKRAFTIG LAKS AS	Board Member	-	420,643	-

Last update: Feb 21, 2026

Related industries3

Direct relationships5

Shares owned by Dag Hjelle

Name	Share class	Total operating income	Total equity	Share
M MEDCIS AS	Ordinære aksjer	402,730	221,964	100 % directly
F FJORD MEDICAL AS		0	138,293	100 % indirectly
F FOLVENGAARD AS	Ordinære aksjer	3,792,389	354,299	60 % directly
F FOLVENGAARD AQUA AS		0	534,500	48 % indirectly
P PURECUT TECHNOLOGIES AS		0	1,092,693	33.33 % indirectly
B BIOSYNTECH AS		0	37,228	20 % indirectly
H HJELLEDALEN KRAFTLAG AS	Ordinære aksjer	1,563,559	2,545,246	9.52 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025